Table 1 IL-17 and IL-23 levels in BP patients at diagnosis according to the extent (A) or to the outcome of the disease (B). Extensive disease was defined as more than 10 new blister daily.

From: Integrating longitudinal serum IL-17 and IL-23 follow-up, along with autoantibodies variation, contributes to predict bullous pemphigoid outcome